The β-catenin binding protein ICAT modulates androgen receptor activity

Molecular Endocrinology

Volumn 25, Issue 10, 2011, Pages 1677-1688

  Zhuo, Ming ^a   Zhu, Chunfang ^a   Sun, Jing Lucy ^a   Weis, William I ^a   Sun, Zijie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; BETA CATENIN; GLUTATHIONE TRANSFERASE; INHIBITOR OF BETA CATENIN AND T CELL FACTOR; MULTIPROTEIN COMPLEX; PROSTATE SPECIFIC ANTIGEN; PROTEIN INHIBITOR; SHORT HAIRPIN RNA; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; CELL GROWTH; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INTERACTION;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, NEOPLASM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN STABILITY; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 80053353943     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1023     Document Type: Article

References (68)

1. Jenster G 1999 The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26:407-421
2. Chang CS, Kokontis J, Liao ST 1988 Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324-326
3. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM 1988 The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275
4. Isaacs JT, Kyprianou N 1989 Biological basis for chemohormonal therapy for prostatic cancer. Cancer Treat Res 46:177-193
5. Kyprianou N, Isaacs JT 1988 Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562
6. Heinlein CA, Chang C 2004 Androgen receptor in prostate cancer. Endocr Rev 25:276-308
7. Feldman BJ, Feldman D 2001 The development of androgen-inde-pendent prostate cancer. Nat Rev Cancer 1:34-45
8. Balk SP 2002 Androgen receptor as a target in androgen-indepen-dent prostate cancer. Urology 60:132-138; discussion 138-139
9. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
10. Verras M, Sun Z 2006 Roles and regulation of Wnt signaling and β-catenin in prostate cancer. Cancer Lett 237:22-32
11. Nusse R 2005 Wnt signaling in disease and in development. Cell Res 15:28-32
12. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I. 2002 Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Gene Dev 16:1066-1076
13. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P 1998 Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Curr Biol 8:573-581
14. Latres E, Chiaur DS, Pagano M 1999 The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin. Oncogene 18:849-854
15. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R 1997 β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804
16. Polakis P 1999 The oncogenic activation of β-catenin. Curr Opin Genet Dev 9:15-21
17. Eastman Q, Grosschedl R 1999 Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11:233-240
18. Truica CI, Byers S, Gelmann EP 2000 β-Catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60:4709-4713
19. Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z 2002 Linking β-catenin to androgen signaling pathway. J Biol Chem 277:11336-11344
20. Pawlowski JE, Ertel JR, Allen MP, Xu M, Butler C, Wilson EM, Wierman ME 2002 Liganded androgen receptor interaction with β-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277:20702-20710
21. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC 2002 The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 277: 17933-17943
22. Chesire DR, Isaacs WB 2002 Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor. Oncogene 21: 8453-8469
23. Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC 2003 Functional localization and competition between the androgen receptor and T-cell factor for nuclear β-catenin: a means for inhibition of the Tcf signaling axis. Oncogene 22:5602-5613
24. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H, Akiyama T 2000 Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein. Gene Dev 14:1741-1749
25. Tutter AV, Fryer CJ, Jones KA 2001 Chromatin-specific regulation of LEF-1- β-catenin transcription activation and inhibition in vitro. Gene Dev 15:3342-3354
26. Katoh M 2001 Molecular cloning and characterization of LZIC, a novel gene encoding ICAT homologous protein with leucine zipper domain. Int J Mol Med 8:611-615
27. Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T, Reifenberger G 2002 Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100:549-556
28. Daniels DL, Weis WI 2002 ICAT inhibits β-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. Mol Cell 10:573-584
29. Graham TA, Clements WK, Kimelman D, Xu W 2002 The crystal structure of the β-catenin/ICAT complex reveals the inhibitory mechanism of ICAT. Mol Cell 10:563-571
30. Lukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, Huber W, Ukkonen E, Brazma A 2010 A global map of human gene expression. Nat Biotechnol 28:322-324
31. Wang G, Wang J, Sadar MD 2008 Crosstalk between the androgen receptor and β-catenin in castrate-resistant prostate cancer. Cancer Res 68:9918-9927
32. Verras M, Brown J, Li X, Nusse R, Sun Z 2004 Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res 64: 8860-8866
33. Peng Y, Lee J, Zhu C, Sun Z 2010 A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription. J Biol Chem 285:11465-11475
34. Li H, Kim JH, Koh SS, Stallcup MR 2004 Synergistic effects of coactivators GRIP1 and β-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. J Biol Chem 279:4212-4220
35. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC 2002 The androgen receptor can promote β-catenin nuclear translocation independently of APC. J Biol Chem 20:17933-17943
36. Graham TA, Weaver C, Mao F, Kimelman D, Xu W 2000 Crystal structure of a β-catenin/Tcf complex. Cell 103:885-896
37. Huber AH, Nelson WJ, Weis WI 1997 Three-dimensional structure of the armadillo repeat region of β-catenin. Cell 90:871-882
38. Hurlstone A, Clevers H 2002 T-cell factors: turn-ons and turn-offs. EMBO J 21:2303-2311
39. Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP 2003 A direct β-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278:30828-30834
40. Koh SS, Li H, Lee YH, Widelitz RB, Chuong CM, Stallcup MR 2002 Synergistic coactivator function by coactivator-associated ar-ginine methyltransferase (CARM) 1 and β-catenin with two different classes of DNA-binding transcriptional activators. J Biol Chem 277:26031-26035
41. Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y 2004 Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin. Mol Cell Biol 24:10689-10702
42. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H 1997 Constitutive transcriptional activation by a β-catenin-Tcf complex in APC- β- colon carcinoma. Science 275:1784-1787
43. Polakis P 2000 Wnt signaling and cancer. Gene Dev 14:1837-1851
44. Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton SR, Kinzler KW, Vogelstein B, Nakamura Y 1992 Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452-4456
45. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW 1992 APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237
46. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y 2000 AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250
47. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW 1997 Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790
48. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P 1997 Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792
49. Voeller HJ, Truica CI, Gelmann EP 1998 β-Catenin mutations in human prostate cancer. Cancer Res 58:2520-2523
50. Chesire DR, Ewing CM, Sauvageot J, Bova GS, Isaacs WB 2000 Detection and analysis of β-catenin mutations in prostate cancer. Prostate 45:323-334
51. Gerstein AV, Almeida TA, Zhao G, Chess E, Shih Ie M, Buhler K, Pienta K, Rubin MA, Vessella R, Papadopoulos N 2002 APC/ CTNNB1 (β-catenin) pathway alterations in human prostate cancers. Gene Chromosome Canc 34:9-16
52. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D, Rabbani SA 2004 Up-regulation of Wnt-1 and β-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345-1356
53. Chesire DR, Ewing CM, Gage WR, Isaacs WB 2002 In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis. Oncogene 21:2679-2694
54. de la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D 2003 β-Catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. Clin Cancer Res 9:1801-1807
55. Mulholland DJ, Dedhar S, Wu H, Nelson CC 2006 PTEN and GSK3 β: key regulators of progression to androgen-independent prostate cancer. Oncogene 25:329-337
56. Gelmann EP 2002 Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
57. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L 1998 A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471
58. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM 2005 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101
59. Delenda C 2004 Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 6(Suppl 1):S125-S138
60. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P 2006 A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109-116
61. Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J, Radeke R, Bukovsky A, Consiglio A, Naldini L, Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L 2001 A new-generation stable inducible packaging cell line for lentiviral vectors A third-generation lentivirus vector with a conditional packaging system. Hum Gene Ther 12:981-997
62. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hop-wood VL, Pathak S, von Eschenbach AC, Chung LW 1994 Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577-2581
63. Sharma M, Li X, Wang Y, Zarnegar M, Huang CY, Palvimo JJ, Lim B, Sun Z 2003 HZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J 22: 6101-6114
64. Sun Z, Yergeau DA, Tuypens T, Tavernier J, Paul CC, Baumann MA, Tenen DG, Ackerman SJ 1995 Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor a subunit gene. J Biol Chem 270:1462-1471
65. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
66. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-AAC(T)) method. Methods 25:402-408
67. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, Kung HJ, Chen HW 2003 Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci USA 100:2226-2230
68. Shang Y, Myers M, Brown M 2002 Formation of the androgen receptor transcription complex. Mol Cell 9:601-610